Home | All trials

[RDF data]
Trial NCT00000178

Resource URI: http://static.linkedct.org/resource/trials/NCT00000178
PropertyValue
linkedct:brief_title Multicenter Trial of Prednisone in Alzheimer's Disease
linkedct:condition <http://static.linkedct.org/resource/condition/829>
linkedct:criteria Inclusion Criteria: - Patients with Alzheimer's disease who are in stable medical condition Exclusion Criteria: - Patients with diabetes or severe osteoporosis
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age N/A
linkedct:eligibility_minimum_age N/A
linkedct:enrollment 0 (xsd:int)
linkedct:firstreceived_date October 29, 1999
linkedct:id NCT00000178
rdfs:label Trial NCT00000178
linkedct:lastchanged_date June 23, 2005
linkedct:lead_sponsor_agency National Institute on Aging (NIA)
linkedct:location <http://static.linkedct.org/resource/location/153094>
linkedct:location <http://static.linkedct.org/resource/location/153764>
linkedct:location <http://static.linkedct.org/resource/location/154764>
linkedct:location <http://static.linkedct.org/resource/location/155052>
linkedct:location <http://static.linkedct.org/resource/location/157178>
linkedct:location <http://static.linkedct.org/resource/location/157873>
linkedct:location <http://static.linkedct.org/resource/location/163294>
linkedct:location <http://static.linkedct.org/resource/location/171858>
linkedct:location <http://static.linkedct.org/resource/location/173811>
linkedct:location <http://static.linkedct.org/resource/location/174084>
linkedct:location <http://static.linkedct.org/resource/location/177909>
linkedct:location <http://static.linkedct.org/resource/location/178981>
linkedct:location <http://static.linkedct.org/resource/location/184744>
linkedct:location <http://static.linkedct.org/resource/location/190347>
linkedct:location <http://static.linkedct.org/resource/location/194482>
linkedct:location <http://static.linkedct.org/resource/location/195834>
linkedct:location <http://static.linkedct.org/resource/location/200364>
linkedct:location <http://static.linkedct.org/resource/location/210154>
linkedct:location <http://static.linkedct.org/resource/location/213264>
linkedct:nct_id NCT00000178
linkedct:number_of_arms 0 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Multicenter Trial of Prednisone in Alzheimer's Disease
linkedct:org_study_id IA0002
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/34878>
linkedct:overall_status Completed
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
foaf:page <http://clinicaltrials.gov/show/NCT00000178>
linkedct:phase Phase 3
linkedct:results_reference <http://static.linkedct.org/resource/results_reference/2190>
linkedct:secondary_id 3U01AG10483-08S2
linkedct:source National Institute on Aging (NIA)
linkedct:study_design Treatment, Randomized, Double-Blind, Placebo Control, Safety/Efficacy Study
linkedct:study_type Interventional
linkedct:summary This is a randomized placebo controlled, double blind study. Patients who meet eligibility criteria and decide to participate in the study will be randomly assigned to receive either drug treatment or a placebo. Neither the patients nor the participating investigators will know who is receiving the drugs and who is receiving the placebo. Participation involves 15 outpatient clinic visits over a 68 week period. Patients take study medication at varying doses (the maximum dose is 20 mg daily), along with calcium and vitamin supplements.
rdf:type linkedct:trials
linkedct:verification_date February 2005